Challenges in operationalizing the DSM-IV clinical significance criterion

Archives of General Psychiatry

Volumn 61, Issue 12, 2004, Pages 1197-1207

  Beals, Janette ^a   Novins, Douglas K ^a   Spicer, Paul ^a   Orton, Heather D ^a   Mitchell, Christina M ^a   Barón, Anna E ^a   Manson, Spero M ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DATA ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EXPERIENCE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; INTERVIEW; MENTAL DISEASE; POPULATION RESEARCH; PREVALENCE; PSYCHIATRIC DIAGNOSIS; RISK ASSESSMENT; SAMPLING; SYMPTOMATOLOGY;

ALGORITHMS; CROSS-SECTIONAL STUDIES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC ERRORS; EPIDEMIOLOGIC RESEARCH DESIGN; EPIDEMIOLOGIC STUDIES; HUMANS; INDIANS, NORTH AMERICAN; MENTAL DISORDERS; MODELS, STATISTICAL; PREDICTIVE VALUE OF TESTS; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; TERMINOLOGY; UNITED STATES;

EID: 10044283062     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.61.12.1197     Document Type: Article

References (50)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
2. Spitzer RL. Values and assumptions in the development of DSM-III DSM-III-R: an insider's perspective and a belated response to Sadler, Hulgus, and Agich's "On values in recent American psychiatric classification." J Nerv Ment Dis. 2001; 189:351-359.
3. Regier DA, Kaelber CT, Rae DS, Farmer ME, Knauper B, Kessler RC, Norquist GS. Limitations of diagnostic criteria and assessment instruments for mental disorders: implications for research and policy. Arch Gen Psychiatry. 1998;55: 109-115.
4. Narrow WE, Rae DS, Robins LN, Regier DA. Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates. Arch Gen Psychiatry. 2002;59:115-123.
5. Wakefield JC, Spitzer RL. Why requiring clinical significance does not solve epidemiology's and DSM's validity problem: response to Regier and Narrow. In: Helzer JE, Hudziak JJ, eds. Defining Psychopathology in the 21st Century: DSM-V and Beyond. Washington, DC: American Psychiatric Publishing Inc; 2002:31-40.
6. Wakefield JC. Diagnosing DSM-IV, I: DSM-IV and the concept of disorder. Behav Res Ther. 1997;35:633-649.
7. Robins LN, Regier DA. Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. New York, NY: The Free Press; 1991.
8. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8-19.
9. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS; National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095-3105.
10. Andrews G, Henderson AS, eds. Unmet Need in Psychiatry. Cambridge, England: Cambridge University Press; 2000.
11. Regier DA, Narrow WE, Rupp A, Rae DS, Kaelber CT. The epidemiology of mental disorder treatment need: community estimates of "medical necessity." In: Andrews G, Henderson S, eds. Unmet Need in Psychiatry: Problems, Resources, Responses. New York, NY: Cambridge University Press; 2000:41-58.
12. Ford WE. Medical necessity: its impact in managed mental health care. Psychiatr Serv. 1998;49:183-184.
13. Cooper B, Singh B. Population research and mental health policy: bridging the gap. Br J Psychiatry. 2000;176:407-411.
14. Wakefield JC. DSM-IV: are we making diagnostic progress? Contemp Psychology. 1996;41:646-652.
15. Frances A. Problems in defining clinical significance in epidemiological studies. Arch Gen Psychiatry. 1998;55:119.
16. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association; 1987.
17. Spitzer RL, Wakefield JC. DSM-IV diagnostic criterion for clinical significance: does it help solve the false positives problem? Am J Psychiatry. 1999;156:1856-1864.
18. Pincus HA, Zarin DA, First M. "Clinical significance" and DSM-IV. Arch Gen Psychiatry. 1998;55:1145.
19. Kendler KS. Setting boundaries for psychiatric disorder. Am J Psychiatry. 1999;156:1845-1848.
20. Wakefield JC, Spitzer RL. Lowered estimates - but of what? Arch Gen Psychiatry. 2002;59:129-130.
21. Regier DA, Narrow WE. Defining clinically significant psychopathology with epidemiologic data. In: Helzer JE, Hudziak JJ, eds. Defining Psychopathology in the 21st Century: DSM-V and Beyond. Washington, DC: American Psychiatric Publishing Inc; 2002:19-30.
22. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition. Washington, DC: American Psychiatric Association; 1980.
23. Slade T, Andrews G. Empirical impact of DSM-IV diagnostic criterion for clinical significance. J Nerv Ment Dis. 2002;190:334-337.
24. Andrews G, Henderson S, Hall W. Prevalence, comorbidity, disability and service utilisation: overview of the Australian National Mental Health Survey. Br J Psychiatry. 2001;178:145-153.
25. Ustun TB, Chatterji S, Rehm J. Limitations of diagnostic paradigm: it doesn't explain "need." Arch Gen Psychiatry. 1998;55:1145-1148.
26. Andrews G, Peters L. The psychometric properties of the Composite International Diagnostic Interview. Soc Psychiatry Psychiatr Epidemiol. 1998;33:80-88.
27. Kessler RC, Wittchen H-U, Abelson JM, McGonagle KA, Kendler KS, Knauper B, Zhao S. Methodological studies of the Composite International Diagnostic Interview (CIDI) in the US National Comorbidity Survey. Int J Methods Psychiatr Res. 1998;7:33-55.
28. Beals J, Manson SM, Mitchell CM, Spicer P; the AI-SUPERPFP Team. Cultural specificity and comparison in psychiatric epidemiology: walking the tightrope in American Indian research. Cult Med Psychiatry. 2003;27:259-289.
29. Beals J, Manson SM, Shore JH, Friedman M, Ashcraft M, Fairbank JA, Schlenger WE. The prevalence of posttraumatic stress disorder among American Indian Vietnam veterans: disparities and context. J Trauma Stress. 2002;15:89-97.
30. Robins LN, Helzer JE, Croughan J, Ratliff KS. National Institute of Mental Health Diagnostic Interview Schedule: its history, characteristics, and validity. Arch Gen Psychiatry. 1981;38:381-389.
31. Spitzer R, Williams J, Gibbon M. Structured Clinical Interview for DSM-III-R, Version NP. New York, NY: New York Psychiatric Institute, Biometrics Research Department; 1987.
32. Eaton WW, Neufeld K, Chen LS, Cai G. A comparison of self-report and clinical diagnostic interviews for depression: diagnostic interview schedule and schedules for clinical assessment in neuropsychiatry in the Baltimore epidemiologic catchment area follow-up. Arch Gen Psychiatry. 2000;57:217-222.
33. Language SAS [computer program]. Version 8.2. Cary, NC: SAS Institute; 2001.
34. SPSS [computer program]. Version 11.0. Chicago, Ill: SPSS Inc; 2001.
35. Kish L. Survey Sampling. New York, NY: John Wiley and Sons; 1965.
36. Cohen J. A coefficient for agreement of nominal scales. Educ Psychol Meas. 1960;20:37-46.
37. Rosner B. Fundamentals of Biostatistics. 5th ed. Pacific Grove, Calif: Duxbury; 2000.
38. Helzer JE, Robins LN, McEvoy LT, Spitznagel EL, Stoltzman RK, Farmer A, Brockington IF. A comparison of clinical and diagnostic interview schedule diagnoses: physician reexamination of lay-interviewed cases in the general population. Arch Gen Psychiatry. 1985;42:657-666.
39. Endicott J, Spitzer RL, Fleiss JL, Cohen J. The global assessment scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 1976;33:766-771.
40. Brugha TS, Jenkins R, Taub N, Meltzer H, Bebbington PE. A general population comparison of the Composite International Diagnostic Interview (CIDI) and the Schedules for Clinical Assessment in Neuropsychiatry (SCAN). Psychol Med. 2001;31:1001-1013.
41. Beals J, Manson SM, Whitesell NR, Spicer P, Novins DK; the AI-SUPERPFP Team. Prevalence of DSM-IV disorders and attendant help-seeking in 2 American Indian reservation populations. Arch Gen Psychiatry. In press.
42. Robins LN. Epidemiology: reflection on testing the validity of psychiatric interviews. Arch Gen Psychiatry. 1985;42:918-924.
43. Berkson J. Limitations of the application of fourfold table analyses to hospital data. Biometric Bull. 1946;2:47-53.
44. Cohen P, Cohen J. The clinician's illusion. Arch Gen Psychiatry. 1984;41:1178-1182.
45. Schuman H, Presser S. Questions and Answers in Attitude Surveys: Experiments on Question Form, Wording, and Context. Thousand Oaks, Calif: Sage Publications Inc; 1996.
46. Rubio-Stipec M, Canino G, Robins LN, Wittchen HU, Sartorius N, Miranda CT. The somatization schedule of the Composite International Diagnostic Interview: the use of the probe chart in 17 different countries. Int J Methods Psychiatr Res. 1993;3:129-136.
47. Buck AA, Gart JJ. Comparison of a screening test and a reference test in epidemiologic studies, I: indices of agreement and their relation to prevalence. Am J Epidemiol. 1966;83:586-592.
48. Kraemer HC, Noda A, O'Hara R. Categorical versus dimensional approaches to diagnosis: methodological challenges. J Psychiatr Res. 2004;38:17-25.
49. Kessler RC. The categorical versus dimensional assessment controversy in the sociology of mental illness. J Health Soc Behav. 2002;43:171-188.
50. Lehman AF. Mental disorders and disability: time to reevaluate the relationship. In: Kupfer DJ, First MB, Regier DA, eds. A Research Agenda for DSM-V. Washington, DC: American Psychiatric Association; 2002:201-218.